Great call indeed. Looking forward to how the mark
Post# of 148190
It will be great once the financing concerns are behind us and the science results can impact the share price. This will help make up some missing valuation from all the great news thus far! The future results are even more important IMO as they include massive markets.
I was a little surprised by the colon cancer IND? I thought they were pursuing MOA so is this just a temp move until they get results in order to add valuation now?
Also surprised about license potential for TNBC?